table of content
1 Introduction to Research & Analysis Reports
1.1 Viral Vector Manufacturing CDMO Services Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Development Scope
1.2.3 Segment by Manufacturing Technology
1.2.4 Segment by Application
1.3 Global Viral Vector Manufacturing CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vector Manufacturing CDMO Services Overall Market Size
2.1 Global Viral Vector Manufacturing CDMO Services Market Size: 2025 VS 2034
2.2 Global Viral Vector Manufacturing CDMO Services Market Size, Prospects & Forecasts: 2021-2034
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Vector Manufacturing CDMO Services Players in Global Market
3.2 Top Global Viral Vector Manufacturing CDMO Services Companies Ranked by Revenue
3.3 Global Viral Vector Manufacturing CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Viral Vector Manufacturing CDMO Services Companies in Global Market, by Revenue in 2025
3.5 Global Companies Viral Vector Manufacturing CDMO Services Product Type
3.6 Tier 1, Tier 2, and Tier 3 Viral Vector Manufacturing CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Viral Vector Manufacturing CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Vector Manufacturing CDMO Services Companies
4 Sights by Type
4.1 Overview
4.1.1 Segmentation by Type - Global Viral Vector Manufacturing CDMO Services Market Size Markets, 2025 & 2034
4.1.2 Adeno-associated Virus
4.1.3 Lentivirus
4.1.4 Adenovirus
4.1.5 HSV
4.1.6 Others
4.2 Segmentation by Type - Global Viral Vector Manufacturing CDMO Services Revenue & Forecasts
4.2.1 Segmentation by Type - Global Viral Vector Manufacturing CDMO Services Revenue, 2021-2026
4.2.2 Segmentation by Type - Global Viral Vector Manufacturing CDMO Services Revenue, 2027-2034
4.2.3 Segmentation by Type - Global Viral Vector Manufacturing CDMO Services Revenue Market Share, 2021-2034
5 Sights by Development Scope
5.1 Overview
5.1.1 Segmentation by Development Scope - Global Viral Vector Manufacturing CDMO Services Market Size Markets, 2025 & 2034
5.1.2 Clinical stage CDMOs
5.1.3 Commercial stage CDMOs
5.1.4 End to end lifecycle CDMOs
5.2 Segmentation by Development Scope - Global Viral Vector Manufacturing CDMO Services Revenue & Forecasts
5.2.1 Segmentation by Development Scope - Global Viral Vector Manufacturing CDMO Services Revenue, 2021-2026
5.2.2 Segmentation by Development Scope - Global Viral Vector Manufacturing CDMO Services Revenue, 2027-2034
5.2.3 Segmentation by Development Scope - Global Viral Vector Manufacturing CDMO Services Revenue Market Share, 2021-2034
6 Sights by Manufacturing Technology
6.1 Overview
6.1.1 Segmentation by Manufacturing Technology - Global Viral Vector Manufacturing CDMO Services Market Size Markets, 2025 & 2034
6.1.2 Adherent Cell Based
6.1.3 Suspension Based
6.2 Segmentation by Manufacturing Technology - Global Viral Vector Manufacturing CDMO Services Revenue & Forecasts
6.2.1 Segmentation by Manufacturing Technology - Global Viral Vector Manufacturing CDMO Services Revenue, 2021-2026
6.2.2 Segmentation by Manufacturing Technology - Global Viral Vector Manufacturing CDMO Services Revenue, 2027-2034
6.2.3 Segmentation by Manufacturing Technology - Global Viral Vector Manufacturing CDMO Services Revenue Market Share, 2021-2034
7 Sights by Application
7.1 Overview
7.1.1 Segmentation by Application - Global Viral Vector Manufacturing CDMO Services Market Size, 2025 & 2034
7.1.2 Vaccine Development
7.1.3 Gene Therapy
7.1.4 Academic Scientific Research Institution
7.1.5 Others
7.2 Segmentation by Application - Global Viral Vector Manufacturing CDMO Services Revenue & Forecasts
7.2.1 Segmentation by Application - Global Viral Vector Manufacturing CDMO Services Revenue, 2021-2026
7.2.2 Segmentation by Application - Global Viral Vector Manufacturing CDMO Services Revenue, 2027-2034
7.2.3 Segmentation by Application - Global Viral Vector Manufacturing CDMO Services Revenue Market Share, 2021-2034
8 Sights Region
8.1 By Region - Global Viral Vector Manufacturing CDMO Services Market Size, 2025 & 2034
8.2 By Region - Global Viral Vector Manufacturing CDMO Services Revenue & Forecasts
8.2.1 By Region - Global Viral Vector Manufacturing CDMO Services Revenue, 2021-2026
8.2.2 By Region - Global Viral Vector Manufacturing CDMO Services Revenue, 2027-2034
8.2.3 By Region - Global Viral Vector Manufacturing CDMO Services Revenue Market Share, 2021-2034
8.3 North America
8.3.1 By Country - North America Viral Vector Manufacturing CDMO Services Revenue, 2021-2034
8.3.2 United States Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.3.3 Canada Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.3.4 Mexico Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.4 Europe
8.4.1 By Country - Europe Viral Vector Manufacturing CDMO Services Revenue, 2021-2034
8.4.2 Germany Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.4.3 France Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.4.4 U.K. Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.4.5 Italy Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.4.6 Russia Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.4.7 Nordic Countries Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.4.8 Benelux Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.5 Asia
8.5.1 By Region - Asia Viral Vector Manufacturing CDMO Services Revenue, 2021-2034
8.5.2 China Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.5.3 Japan Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.5.4 South Korea Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.5.5 Southeast Asia Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.5.6 India Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.6 South America
8.6.1 By Country - South America Viral Vector Manufacturing CDMO Services Revenue, 2021-2034
8.6.2 Brazil Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.6.3 Argentina Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.7 Middle East & Africa
8.7.1 By Country - Middle East & Africa Viral Vector Manufacturing CDMO Services Revenue, 2021-2034
8.7.2 Turkey Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.7.3 Israel Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.7.4 Saudi Arabia Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
8.7.5 UAE Viral Vector Manufacturing CDMO Services Market Size, 2021-2034
9 Companies Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Corporate Summary
9.1.2 Thermo Fisher Scientific Business Overview
9.1.3 Thermo Fisher Scientific Viral Vector Manufacturing CDMO Services Major Product Offerings
9.1.4 Thermo Fisher Scientific Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.1.5 Thermo Fisher Scientific Key News & Latest Developments
9.2 Lonza
9.2.1 Lonza Corporate Summary
9.2.2 Lonza Business Overview
9.2.3 Lonza Viral Vector Manufacturing CDMO Services Major Product Offerings
9.2.4 Lonza Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.2.5 Lonza Key News & Latest Developments
9.3 Catalent
9.3.1 Catalent Corporate Summary
9.3.2 Catalent Business Overview
9.3.3 Catalent Viral Vector Manufacturing CDMO Services Major Product Offerings
9.3.4 Catalent Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.3.5 Catalent Key News & Latest Developments
9.4 Charles River
9.4.1 Charles River Corporate Summary
9.4.2 Charles River Business Overview
9.4.3 Charles River Viral Vector Manufacturing CDMO Services Major Product Offerings
9.4.4 Charles River Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.4.5 Charles River Key News & Latest Developments
9.5 Merck
9.5.1 Merck Corporate Summary
9.5.2 Merck Business Overview
9.5.3 Merck Viral Vector Manufacturing CDMO Services Major Product Offerings
9.5.4 Merck Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.5.5 Merck Key News & Latest Developments
9.6 SK pharmteco
9.6.1 SK pharmteco Corporate Summary
9.6.2 SK pharmteco Business Overview
9.6.3 SK pharmteco Viral Vector Manufacturing CDMO Services Major Product Offerings
9.6.4 SK pharmteco Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.6.5 SK pharmteco Key News & Latest Developments
9.7 Oxford Biomedica
9.7.1 Oxford Biomedica Corporate Summary
9.7.2 Oxford Biomedica Business Overview
9.7.3 Oxford Biomedica Viral Vector Manufacturing CDMO Services Major Product Offerings
9.7.4 Oxford Biomedica Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.7.5 Oxford Biomedica Key News & Latest Developments
9.8 AGC Biologics?MolMed?
9.8.1 AGC Biologics?MolMed? Corporate Summary
9.8.2 AGC Biologics?MolMed? Business Overview
9.8.3 AGC Biologics?MolMed? Viral Vector Manufacturing CDMO Services Major Product Offerings
9.8.4 AGC Biologics?MolMed? Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.8.5 AGC Biologics?MolMed? Key News & Latest Developments
9.9 Gene Universal
9.9.1 Gene Universal Corporate Summary
9.9.2 Gene Universal Business Overview
9.9.3 Gene Universal Viral Vector Manufacturing CDMO Services Major Product Offerings
9.9.4 Gene Universal Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.9.5 Gene Universal Key News & Latest Developments
9.10 Polyplus (Sartorius)
9.10.1 Polyplus (Sartorius) Corporate Summary
9.10.2 Polyplus (Sartorius) Business Overview
9.10.3 Polyplus (Sartorius) Viral Vector Manufacturing CDMO Services Major Product Offerings
9.10.4 Polyplus (Sartorius) Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.10.5 Polyplus (Sartorius) Key News & Latest Developments
9.11 CCRM
9.11.1 CCRM Corporate Summary
9.11.2 CCRM Business Overview
9.11.3 CCRM Viral Vector Manufacturing CDMO Services Major Product Offerings
9.11.4 CCRM Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.11.5 CCRM Key News & Latest Developments
9.12 FUJIFILM Diosynth Biotechnologies
9.12.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
9.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
9.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Major Product Offerings
9.12.4 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.12.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
9.13 Biovian
9.13.1 Biovian Corporate Summary
9.13.2 Biovian Business Overview
9.13.3 Biovian Viral Vector Manufacturing CDMO Services Major Product Offerings
9.13.4 Biovian Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.13.5 Biovian Key News & Latest Developments
9.14 Miltenyi Bioindustry
9.14.1 Miltenyi Bioindustry Corporate Summary
9.14.2 Miltenyi Bioindustry Business Overview
9.14.3 Miltenyi Bioindustry Viral Vector Manufacturing CDMO Services Major Product Offerings
9.14.4 Miltenyi Bioindustry Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.14.5 Miltenyi Bioindustry Key News & Latest Developments
9.15 Aldevron
9.15.1 Aldevron Corporate Summary
9.15.2 Aldevron Business Overview
9.15.3 Aldevron Viral Vector Manufacturing CDMO Services Major Product Offerings
9.15.4 Aldevron Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.15.5 Aldevron Key News & Latest Developments
9.16 Takara Bio
9.16.1 Takara Bio Corporate Summary
9.16.2 Takara Bio Business Overview
9.16.3 Takara Bio Viral Vector Manufacturing CDMO Services Major Product Offerings
9.16.4 Takara Bio Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.16.5 Takara Bio Key News & Latest Developments
9.17 Yposkesi
9.17.1 Yposkesi Corporate Summary
9.17.2 Yposkesi Business Overview
9.17.3 Yposkesi Viral Vector Manufacturing CDMO Services Major Product Offerings
9.17.4 Yposkesi Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.17.5 Yposkesi Key News & Latest Developments
9.18 Genezen
9.18.1 Genezen Corporate Summary
9.18.2 Genezen Business Overview
9.18.3 Genezen Viral Vector Manufacturing CDMO Services Major Product Offerings
9.18.4 Genezen Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.18.5 Genezen Key News & Latest Developments
9.19 Exthera
9.19.1 Exthera Corporate Summary
9.19.2 Exthera Business Overview
9.19.3 Exthera Viral Vector Manufacturing CDMO Services Major Product Offerings
9.19.4 Exthera Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.19.5 Exthera Key News & Latest Developments
9.20 Flash Therapeutics
9.20.1 Flash Therapeutics Corporate Summary
9.20.2 Flash Therapeutics Business Overview
9.20.3 Flash Therapeutics Viral Vector Manufacturing CDMO Services Major Product Offerings
9.20.4 Flash Therapeutics Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.20.5 Flash Therapeutics Key News & Latest Developments
9.21 VIVEBiotech
9.21.1 VIVEBiotech Corporate Summary
9.21.2 VIVEBiotech Business Overview
9.21.3 VIVEBiotech Viral Vector Manufacturing CDMO Services Major Product Offerings
9.21.4 VIVEBiotech Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.21.5 VIVEBiotech Key News & Latest Developments
9.22 FinVector
9.22.1 FinVector Corporate Summary
9.22.2 FinVector Business Overview
9.22.3 FinVector Viral Vector Manufacturing CDMO Services Major Product Offerings
9.22.4 FinVector Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.22.5 FinVector Key News & Latest Developments
9.23 uBriGene
9.23.1 uBriGene Corporate Summary
9.23.2 uBriGene Business Overview
9.23.3 uBriGene Viral Vector Manufacturing CDMO Services Major Product Offerings
9.23.4 uBriGene Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.23.5 uBriGene Key News & Latest Developments
9.24 Eurogentec
9.24.1 Eurogentec Corporate Summary
9.24.2 Eurogentec Business Overview
9.24.3 Eurogentec Viral Vector Manufacturing CDMO Services Major Product Offerings
9.24.4 Eurogentec Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.24.5 Eurogentec Key News & Latest Developments
9.25 VGXI
9.25.1 VGXI Corporate Summary
9.25.2 VGXI Business Overview
9.25.3 VGXI Viral Vector Manufacturing CDMO Services Major Product Offerings
9.25.4 VGXI Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.25.5 VGXI Key News & Latest Developments
9.26 GenScript ProBio
9.26.1 GenScript ProBio Corporate Summary
9.26.2 GenScript ProBio Business Overview
9.26.3 GenScript ProBio Viral Vector Manufacturing CDMO Services Major Product Offerings
9.26.4 GenScript ProBio Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.26.5 GenScript ProBio Key News & Latest Developments
9.27 EurekaBio
9.27.1 EurekaBio Corporate Summary
9.27.2 EurekaBio Business Overview
9.27.3 EurekaBio Viral Vector Manufacturing CDMO Services Major Product Offerings
9.27.4 EurekaBio Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.27.5 EurekaBio Key News & Latest Developments
9.28 Obio Technology
9.28.1 Obio Technology Corporate Summary
9.28.2 Obio Technology Business Overview
9.28.3 Obio Technology Viral Vector Manufacturing CDMO Services Major Product Offerings
9.28.4 Obio Technology Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.28.5 Obio Technology Key News & Latest Developments
9.29 GeneSail Biotech
9.29.1 GeneSail Biotech Corporate Summary
9.29.2 GeneSail Biotech Business Overview
9.29.3 GeneSail Biotech Viral Vector Manufacturing CDMO Services Major Product Offerings
9.29.4 GeneSail Biotech Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.29.5 GeneSail Biotech Key News & Latest Developments
9.30 VectorBuilder
9.30.1 VectorBuilder Corporate Summary
9.30.2 VectorBuilder Business Overview
9.30.3 VectorBuilder Viral Vector Manufacturing CDMO Services Major Product Offerings
9.30.4 VectorBuilder Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.30.5 VectorBuilder Key News & Latest Developments
9.31 WuXi ATU
9.31.1 WuXi ATU Corporate Summary
9.31.2 WuXi ATU Business Overview
9.31.3 WuXi ATU Viral Vector Manufacturing CDMO Services Major Product Offerings
9.31.4 WuXi ATU Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.31.5 WuXi ATU Key News & Latest Developments
9.32 Ubrigene
9.32.1 Ubrigene Corporate Summary
9.32.2 Ubrigene Business Overview
9.32.3 Ubrigene Viral Vector Manufacturing CDMO Services Major Product Offerings
9.32.4 Ubrigene Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.32.5 Ubrigene Key News & Latest Developments
9.33 Porton Biologics
9.33.1 Porton Biologics Corporate Summary
9.33.2 Porton Biologics Business Overview
9.33.3 Porton Biologics Viral Vector Manufacturing CDMO Services Major Product Offerings
9.33.4 Porton Biologics Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.33.5 Porton Biologics Key News & Latest Developments
9.34 Pharmaron
9.34.1 Pharmaron Corporate Summary
9.34.2 Pharmaron Business Overview
9.34.3 Pharmaron Viral Vector Manufacturing CDMO Services Major Product Offerings
9.34.4 Pharmaron Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.34.5 Pharmaron Key News & Latest Developments
9.35 PackGene Biotechnology
9.35.1 PackGene Biotechnology Corporate Summary
9.35.2 PackGene Biotechnology Business Overview
9.35.3 PackGene Biotechnology Viral Vector Manufacturing CDMO Services Major Product Offerings
9.35.4 PackGene Biotechnology Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.35.5 PackGene Biotechnology Key News & Latest Developments
9.36 Hillgene
9.36.1 Hillgene Corporate Summary
9.36.2 Hillgene Business Overview
9.36.3 Hillgene Viral Vector Manufacturing CDMO Services Major Product Offerings
9.36.4 Hillgene Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.36.5 Hillgene Key News & Latest Developments
9.37 Asymchem
9.37.1 Asymchem Corporate Summary
9.37.2 Asymchem Business Overview
9.37.3 Asymchem Viral Vector Manufacturing CDMO Services Major Product Offerings
9.37.4 Asymchem Viral Vector Manufacturing CDMO Services Revenue in Global Market (2021-2026)
9.37.5 Asymchem Key News & Latest Developments
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
